Atheroprotective Effects and Mechanisms of Postmarketing Chinese Patent Formulas in Atherosclerosis Models: A Systematic Review
- PMID: 34873408
- PMCID: PMC8643251
- DOI: 10.1155/2021/4010607
Atheroprotective Effects and Mechanisms of Postmarketing Chinese Patent Formulas in Atherosclerosis Models: A Systematic Review
Abstract
Background: Some postmarketing Chinese patent formulas have been widely used to treat atherosclerosis (AS) and play critical roles in Chinese healthcare. However, the usage of these herbs is yet controversial due to unclear effects and lack of understanding of the mechanism of action. With the modernization of traditional Chinese formulas, we are to elucidate the atheroprotective properties of these remedies from successful postmarketing experiments in vivo.
Methods: In this systematic review, we critically searched the databases, applied stringent criteria, assessed the methodological quality, and examined the current evidence in vivo.
Results: Consequently, 60 studies were included in the present qualitative synthesis. Data on models, high-fat diet, intervention time, outcome measures, efficacy, and mechanisms were collected. Finally, 23 formulas that could alleviate AS were correlated to the amelioration of plaques, improvement of plaque stability, modification of lipid level and lipid metabolism, and the effects of anti-inflammation and antioxidant stress with multiple components and targets. However, the methodological quality was low and incomplete among the included literature.
Conclusions: Thus, taken together, the studies on postmarketing Chinese patent formulas would provide a novel approach to improve the treatment of AS, and rigorously designed studies would provide high-quality evidence.
Copyright © 2021 Shiqi Chen et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding the publication of this article.
Figures
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Systematic Review: Guideline-Based Approach for the Management of Asthma and Subtypes via Chinese Medicine.Evid Based Complement Alternat Med. 2021 Jan 7;2021:4319657. doi: 10.1155/2021/4319657. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33505494 Free PMC article. Review.
-
Atheroprotective effects and molecular targets of bioactive compounds from traditional Chinese medicine.Pharmacol Res. 2018 Sep;135:212-229. doi: 10.1016/j.phrs.2018.07.012. Epub 2018 Aug 11. Pharmacol Res. 2018. PMID: 30107203 Review.
-
Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.J Ethnopharmacol. 2016 Aug 2;189:61-80. doi: 10.1016/j.jep.2016.05.025. Epub 2016 May 11. J Ethnopharmacol. 2016. PMID: 27180315 Review.
-
Compound Formulas of Traditional Chinese Medicine for the Common Cold: Systematic Review of Randomized, Placebo-controlled Trials.Altern Ther Health Med. 2015 Nov-Dec;21(6):48-57. Altern Ther Health Med. 2015. PMID: 26567449 Review.
Cited by
-
Candidate SNP Markers Significantly Altering the Affinity of TATA-Binding Protein for the Promoters of Human Hub Genes for Atherogenesis, Atherosclerosis and Atheroprotection.Int J Mol Sci. 2023 May 19;24(10):9010. doi: 10.3390/ijms24109010. Int J Mol Sci. 2023. PMID: 37240358 Free PMC article.
References
-
- World Health Organization. Key Facts of Cardiovascular Diseases (CVDs) Geneva, Switzerland: WHO; 2021. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-disea... .
Publication types
LinkOut - more resources
Full Text Sources
Research Materials